Literature DB >> 26358277

Starting a High-Quality Pancreatic Surgery Program at a Community Hospital.

Jeffrey M Hardacre1, Siavash Raigani2, John Dumot3.   

Abstract

BACKGROUND: Most literature suggests that pancreatic resections should be done by high-volume surgeons at high-volume hospitals to optimize patient outcomes. However, patient preference and insurance requirements may restrict hospital location. After careful planning, a high-volume pancreatic surgeon started performing pancreatectomies at a community hospital.
METHODS: Sixty pancreatectomies were performed at an academic medical center and 28 at a 144-bed community, non-teaching hospital. Sixty-day outcomes were recorded.
RESULTS: There were no statistically significant differences between the academic medical center and community hospital with regard to the median age of the patients (66 vs. 61 years), the gender distribution (57 vs. 64 % female), or the median BMI (28 vs. 26 kg/m(2)). There was a significant difference in the American Society of Anesthesiologists class distribution between the academic medical center and community hospital (1; 0 vs. 4 %, 2; 7 vs. 21 %, 3; 88 vs. 75 %, 4; 5 vs. 0 %, p = 0.006). The median length of stay (LOS) for 17 pancreaticoduodenectomy/total pancreatectomy patients at the community hospital was significantly less than for 39 patients at the academic medical center (5 vs. 7 days, p = 0.006). Eleven distal pancreatectomy/splenectomy patients at the community hospital tended to have a shorter median LOS than 21 patients at the academic medical center (4 vs. 5 days, p = 0.25). Accordion ≥ 3 complications (7 vs. 27 %) and readmissions (11 vs. 22 %) tended to be lower at the community hospital than the academic medical center. Greater than 80 % of patients with adenocarcinoma at both hospital settings who were recommended to receive adjuvant therapy started their treatment within 60 days of surgery.
CONCLUSIONS: With appropriate planning and careful patient selection, high-quality pancreatic surgery can be performed at a community hospital by a high-volume pancreatic surgeon.

Entities:  

Keywords:  Community hospital; Pancreatectomy; Regionalization

Mesh:

Year:  2015        PMID: 26358277     DOI: 10.1007/s11605-015-2937-6

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  25 in total

1.  Frequency with which surgeons undertake pancreaticoduodenectomy determines length of stay, hospital charges, and in-hospital mortality.

Authors:  A S Rosemurgy; M Bloomston; F M Serafini; B Coon; M M Murr; L C Carey
Journal:  J Gastrointest Surg       Date:  2001 Jan-Feb       Impact factor: 3.452

2.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

3.  Initiation of a critical pathway for pancreaticoduodenectomy at an academic institution--the first step in multidisciplinary team building.

Authors:  Eugene P Kennedy; Ernest L Rosato; Patricia K Sauter; Laura M Rosenberg; Cataldo Doria; Ignazio R Marino; Karen A Chojnacki; Adam C Berger; Charles J Yeo
Journal:  J Am Coll Surg       Date:  2007-05       Impact factor: 6.113

4.  HPB surgery can be safely performed in a community teaching hospital.

Authors:  Andrei Cocieru; Pierre F Saldinger
Journal:  J Gastrointest Surg       Date:  2010-05-18       Impact factor: 3.452

5.  A neoadjuvant strategy for pancreatic adenocarcinoma increases the likelihood of receiving all components of care: lessons from a single-institution database.

Authors:  May Piperdi; Theodore P McDade; Joon K Shim; Bilal Piperdi; Sidney P Kadish; Mary E Sullivan; Giles F Whalen; Jennifer F Tseng
Journal:  HPB (Oxford)       Date:  2010-04       Impact factor: 3.647

6.  Perioperative outcome after pancreatic head resection: a 10-year series of a specialized surgeon in a university hospital and a community hospital.

Authors:  Hartwig Riediger; Ulrich Adam; Stefan Utzolino; Hannes P Neeff; Ulrich T Hopt; Frank Makowiec
Journal:  J Gastrointest Surg       Date:  2014-06-05       Impact factor: 3.452

7.  The learning curve in pancreatic surgery.

Authors:  Jennifer F Tseng; Peter W T Pisters; Jeffrey E Lee; Huamin Wang; Henry F Gomez; Charlotte C Sun; Douglas B Evans
Journal:  Surgery       Date:  2007-01-22       Impact factor: 3.982

8.  Major pancreatic resections for suspected cancer in a community-based teaching hospital: lessons learned.

Authors:  Ramaz E Metreveli; Katherine Sahm; Raafat Abdel-Misih; Nicholas J Petrelli
Journal:  J Surg Oncol       Date:  2007-03-01       Impact factor: 3.454

9.  Complex pancreatic surgery: safety and feasibility in the community setting.

Authors:  Ronald S Chamberlain; Matthew Tichauer; Zachary Klaassen; Prakash R Paragi
Journal:  J Gastrointest Surg       Date:  2011-01       Impact factor: 3.452

10.  Impact of hospital volume on operative mortality for major cancer surgery.

Authors:  C B Begg; L D Cramer; W J Hoskins; M F Brennan
Journal:  JAMA       Date:  1998-11-25       Impact factor: 56.272

View more
  3 in total

1.  Potential impact of a volume pledge on spatial access: A population-level analysis of patients undergoing pancreatectomy.

Authors:  Zhi Ven Fong; Andrew P Loehrer; Carlos Fernández-Del Castillo; Yanik J Bababekov; Ginger Jin; Cristina R Ferrone; Andrew L Warshaw; Lara N Traeger; Matthew M Hutter; Keith D Lillemoe; David C Chang
Journal:  Surgery       Date:  2017-05-11       Impact factor: 3.982

2.  Distal pancreatectomy outcomes: Perspectives from a community-based teaching institution.

Authors:  Muhammad Umair Bashir; Apostolos Kandilis; Nancy M Jackson; Janak A Parikh; Michael J Jacobs
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2020-05-31

Review 3.  Managing Polypharmacy in Older Adults with Cancer Across Different Healthcare Settings.

Authors:  Andrew Whitman; Paige Erdeljac; Caroline Jones; Nicole Pillarella; Ginah Nightingale
Journal:  Drug Healthc Patient Saf       Date:  2021-04-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.